The klotho peptide has become one of the most searched terms in longevity research, reflecting growing scientific and public interest in a protein first identified as an aging suppressor gene in 1997. While klotho is technically a transmembrane protein rather than a classical peptide, its soluble circulating form functions as a hormone with peptide-like signaling properties, and it is extensively searched alongside peptide compounds by researchers interested in anti-aging biology.

This research guide covers klotho’s molecular biology, its roles in kidney health, brain function, and longevity signaling, key findings from human genetic studies, and how klotho research connects to the broader landscape of anti-aging compounds available to investigators.

What Is Klotho and Why Is It Called the Longevity Protein?

Klotho was discovered by Makoto Kuro-o and colleagues when they observed that mice with a disruption of the klotho gene developed a syndrome resembling accelerated human aging: shortened lifespan, skin atrophy, osteoporosis, vascular calcification, pulmonary emphysema, and infertility. Conversely, mice engineered to overexpress klotho lived 20 to 30% longer than wild-type controls (Kuro-o et al., 1997, Nature).

Named after the Greek goddess Clotho, who spins the thread of life, klotho exists in three forms. Alpha-klotho is the most studied form and the primary focus of longevity research. It is expressed as a single-pass transmembrane protein predominantly in the kidney distal tubules and brain choroid plexus. The extracellular domain can be cleaved by secretases (ADAM10 and ADAM17) to release a soluble circulating form that functions as a hormone.

Beta-klotho and gamma-klotho are structurally related family members with distinct tissue distributions and functions. Beta-klotho is primarily expressed in the liver and serves as a co-receptor for FGF21 and FGF19, while gamma-klotho (also called lactase-like klotho) has a more limited characterized function. This guide focuses on alpha-klotho, the form most relevant to aging and longevity research.

How Does Klotho Protein Function in the Body?

Klotho operates through multiple mechanisms that collectively regulate mineral metabolism, cellular stress resistance, and aging-associated pathways.

FGF23 Co-Receptor Function

The most well-characterized function of membrane-bound klotho is as an obligate co-receptor for fibroblast growth factor 23 (FGF23). FGF23, produced by osteocytes in bone, signals through FGF receptor 1c (FGFR1c) in the kidney, but this signaling requires klotho to form a stable ternary complex. The FGF23-klotho-FGFR1c axis regulates phosphate homeostasis by promoting urinary phosphate excretion and suppressing 1,25-dihydroxyvitamin D synthesis.

This phosphate-regulatory function has direct aging implications. Phosphate toxicity is increasingly recognized as a driver of vascular calcification, chronic kidney disease progression, and accelerated aging. Klotho’s role in maintaining phosphate balance provides a mechanistic link between mineral metabolism and longevity.

Soluble Klotho as a Circulating Hormone

Soluble klotho, released by ectodomain shedding, circulates in blood and cerebrospinal fluid at measurable concentrations. Soluble klotho acts as a humoral factor with several identified activities that explain many of the klotho peptide benefits observed in research.

It functions as an enzyme with sialidase activity, modifying cell-surface glycoproteins including ion channels (TRPV5 and ROMK) to regulate calcium and potassium handling in the kidney. Soluble klotho also suppresses insulin/IGF-1 signaling by inhibiting the insulin receptor and IGF-1 receptor tyrosine kinase activity, a mechanism directly relevant to the well-established longevity pathway of reduced insulin/IGF-1 signaling.

Additionally, soluble klotho inhibits Wnt signaling by binding Wnt ligands and preventing receptor engagement. Since excessive Wnt activation drives cellular senescence and stem cell exhaustion, klotho’s Wnt-suppressive activity may protect the stem cell niche during aging.

Antioxidant and Anti-Inflammatory Mechanisms

Klotho upregulates expression of manganese superoxide dismutase (MnSOD) and other antioxidant enzymes through suppression of insulin/IGF-1 signaling and activation of FoxO transcription factors. This reduces oxidative stress at the cellular level. Klotho also suppresses NF-kB-mediated inflammatory signaling, reducing the chronic low-grade inflammation (inflammaging) that characterizes biological aging.

Recent studies have identified additional klotho anti-aging mechanisms involving autophagy regulation. Klotho promotes autophagy, the cellular recycling process that clears damaged organelles and misfolded proteins. Enhanced autophagy is a conserved feature of long-lived organisms and a downstream effect of both caloric restriction and rapamycin treatment, two of the most validated longevity interventions. Klotho’s autophagy-promoting activity may represent another convergent mechanism linking this protein to the core biology of aging.

Klotho and Kidney Health Research

The kidney is the primary organ of klotho expression, and klotho research in nephrology has produced some of the most clinically translatable findings.

Chronic Kidney Disease

Klotho expression declines early in chronic kidney disease (CKD), often before clinical markers of kidney dysfunction become apparent. This decline is both a consequence and a driver of disease progression: reduced klotho impairs phosphate handling, leading to hyperphosphatemia, secondary hyperparathyroidism, and vascular calcification, a cascade that accelerates kidney damage and cardiovascular mortality.

Multiple preclinical studies have demonstrated that klotho supplementation or gene delivery can slow CKD progression, reduce renal fibrosis, and improve kidney function in animal models. A comprehensive review of klotho’s role in CKD pathophysiology documented the protein’s involvement in virtually every aspect of the uremic syndrome, from mineral metabolism to cardiovascular complications (PubMed: klotho in chronic kidney disease). These findings have generated intense interest in klotho as both a biomarker for early CKD detection and a potential therapeutic target.

Acute Kidney Injury

In acute kidney injury (AKI) models, klotho expression drops precipitously. Exogenous klotho administration before or shortly after AKI insult reduces tubular damage, decreases inflammatory cell infiltration, and accelerates functional recovery. The protective mechanism involves klotho’s anti-apoptotic, anti-inflammatory, and anti-fibrotic activities acting in concert to preserve renal tubular integrity.

Urinary and plasma klotho levels are being investigated as early biomarkers for AKI risk stratification, with lower baseline klotho concentrations predicting higher susceptibility to renal injury in surgical and critically ill populations.

Klotho and Brain Function Research

The brain is the second major site of klotho expression, concentrated in the choroid plexus where cerebrospinal fluid is produced. Klotho anti-aging research in neuroscience has revealed surprising cognitive effects.

Cognitive Enhancement

A landmark study by Dubal and colleagues demonstrated that mice overexpressing klotho showed enhanced cognitive performance in multiple behavioral tests of learning and memory, including the Morris water maze and contextual fear conditioning. These cognitive benefits occurred even in young adult mice, suggesting klotho does not merely prevent age-related decline but actively enhances neural function (Dubal et al., 2014, Cell Reports).

The mechanism appears to involve klotho’s enhancement of NMDA receptor-dependent synaptic plasticity. Klotho overexpression increased GluN2B-containing NMDA receptor abundance at synapses, a receptor subtype associated with enhanced long-term potentiation (LTP) and memory formation.

Human Genetic Studies

In humans, a common klotho variant called KL-VS (present in approximately 20 to 25% of the population as heterozygotes) has been associated with higher circulating klotho levels, better cognitive performance on executive function tasks, and larger prefrontal cortex volume. Heterozygous carriers of KL-VS perform better on cognitive tests across age groups, from young adults through elderly individuals.

Interestingly, the cognitive benefits follow a heterozygote advantage pattern: one copy of the KL-VS variant is beneficial, but homozygosity (two copies) is associated with reduced lifespan and no cognitive benefit, suggesting a gene-dosage effect with an optimal range.

Neurodegenerative Disease Relevance

In Alzheimer’s disease, lower cerebrospinal fluid klotho levels correlate with greater amyloid and tau pathology burden. In Parkinson’s disease models, klotho overexpression protects dopaminergic neurons from oxidative stress-induced death. These findings have positioned klotho research at the intersection of aging biology and neurodegeneration, making it relevant to the broader neuroprotective peptide research landscape.

Klotho in Human Longevity Studies

The translation of klotho’s anti-aging effects from animal models to human aging research has produced compelling epidemiological findings.

Circulating soluble klotho levels decline with age in humans, from peak levels in early childhood through progressive decline beginning around age 40. Several large cohort studies have found that higher circulating klotho levels independently predict lower all-cause mortality, reduced cardiovascular event rates, and better preserved kidney function over time.

The KL-VS heterozygote advantage for longevity has been replicated across multiple ethnic populations and geographic cohorts. A meta-analysis found that KL-VS heterozygosity was associated with approximately 6% longer lifespan compared to non-carriers, a modest but statistically robust effect consistent with the polygenic nature of human longevity.

Lifestyle factors known to promote healthy aging, including regular exercise, caloric moderation, and reduced phosphate intake, have been associated with maintained klotho expression. This suggests that klotho may mediate some of the anti-aging benefits of established longevity-promoting behaviors.

For a comprehensive overview of longevity-associated compounds and their mechanisms, see our best peptides for longevity and anti-aging guide.

How Klotho Connects to Longevity Peptide Research

While klotho itself is a protein rather than a classical peptide, its biological functions intersect extensively with several peptide compound categories studied by the research community.

Telomere Biology

Klotho’s suppression of oxidative stress and Wnt signaling overlaps mechanistically with compounds that target telomere maintenance, the other major molecular clock of cellular aging. Epitalon, a tetrapeptide that activates telomerase through pineal gland mechanisms, addresses the telomere-shortening aspect of aging while klotho addresses the mineral metabolism, stem cell, and inflammatory aspects. Together, these approaches cover complementary domains of aging biology.

Our epitalon telomere and anti-aging peptide guide covers the telomere-targeted approach in detail.

Mitochondrial Peptides

Klotho’s antioxidant upregulation and cellular stress resistance mechanisms complement the mitochondrial-derived peptide class including MOTS-c and humanin. While klotho acts primarily through extracellular and receptor-mediated signaling, mitochondrial peptides provide intracellular protection and metabolic regulation. Researchers designing comprehensive aging intervention protocols often consider both categories.

The MOTS-c peptide metabolic health guide covers the mitochondrial peptide perspective on aging and metabolism.

NAD+ Biology

Klotho expression and NAD+ metabolism intersect through shared downstream effectors including sirtuins and FoxO transcription factors. NAD+ precursors (NMN, NR) activate sirtuins that in turn promote stress resistance and cellular maintenance pathways overlapping with klotho’s effects. NAD+ supplementation research is covered in our NAD+ complete guide.

Current Challenges and Future Directions in Klotho Research

Despite the compelling preclinical and epidemiological data, several challenges remain before klotho’s potential can be fully realized in research and therapeutic applications.

Production of recombinant soluble klotho at research scale remains technically challenging. The full-length soluble klotho ectodomain is a large glycoprotein (approximately 130 kDa) requiring mammalian cell expression systems for proper folding and glycosylation. This limits availability and increases cost compared to smaller peptide compounds.

Delivery and pharmacokinetics present additional hurdles. Soluble klotho has a relatively short circulating half-life, and achieving sustained therapeutic levels through protein administration requires frequent dosing or specialized delivery systems. Gene therapy approaches using adeno-associated viral (AAV) vectors to restore klotho expression in target tissues have shown promise in animal models but remain in early development.

Small-molecule klotho modulators, compounds that increase endogenous klotho expression or mimic klotho’s activity, represent an active area of drug discovery. Identification of such compounds could transform klotho research by providing pharmacologically convenient tools for chronic studies.

Researchers interested in the practical application of anti-aging peptide stacking protocols can explore our anti-aging peptide stack guide for approaches using currently available compounds.

Where to Buy Related Longevity Research Compounds

While klotho protein itself is not currently available as a standard research peptide due to its size and production complexity, PSPeptides offers several related longevity compounds that target complementary aging pathways.

Epitalon from PSPeptides is a synthetic tetrapeptide that activates telomerase to address telomere-mediated aging, complementing klotho’s mineral metabolism and stress resistance pathways. NAD+ from PSPeptides supports sirtuin activation and cellular energy metabolism, intersecting with klotho’s downstream signaling effectors.

PSPeptides provides the quality infrastructure essential for longevity research:

• Certificate of Analysis (COA) with every order documenting purity, identity, and potency through HPLC and mass spectrometry verification
• Same-day shipping on qualifying orders with stability-appropriate packaging
• Afterpay and Klarna flexible payment options for research programs on varied budgets
• Research supply bundles including bacteriostatic water and reconstitution accessories for complete experimental preparation

Researchers can build comprehensive longevity protocols by combining telomere-targeted (epitalon), metabolic (NAD+, MOTS-c), and mitochondrial peptide approaches to address multiple aging hallmarks simultaneously.

Frequently Asked Questions About Klotho

Is klotho a peptide or a protein?

Klotho is technically a transmembrane protein with a large extracellular domain of approximately 130 kDa. However, the soluble cleaved form that circulates in blood and cerebrospinal fluid functions as a hormone with signaling properties similar to peptide hormones. It appears in peptide research contexts because longevity researchers frequently study klotho alongside peptide compounds targeting aging pathways.

How does klotho protein promote longevity?

Klotho promotes longevity through multiple mechanisms: it regulates phosphate homeostasis by serving as a co-receptor for FGF23, suppresses insulin/IGF-1 signaling (a conserved longevity pathway), inhibits Wnt-driven cellular senescence, upregulates antioxidant defenses through FoxO activation, and reduces chronic inflammation. Mice overexpressing klotho live 20 to 30% longer than controls, while klotho-deficient mice show accelerated aging and premature death.

What research compounds complement klotho’s anti-aging mechanisms?

Epitalon targets telomere maintenance through telomerase activation, addressing the replicative aging pathway. NAD+ precursors activate sirtuins that share downstream effectors with klotho signaling. MOTS-c provides metabolic regulation through AMPK activation and mitochondrial function support. Together, these compounds and klotho cover complementary domains of aging biology, from mineral metabolism and stress resistance to telomere length and cellular energy.

Do klotho levels decline with age in humans?

Yes. Circulating soluble klotho levels peak in early childhood and decline progressively beginning around age 40. Higher circulating klotho levels independently predict lower all-cause mortality and better preserved kidney function. The common KL-VS genetic variant, carried by approximately 20 to 25% of the population as heterozygotes, is associated with higher klotho levels, better cognitive function, and modestly extended lifespan.

All PSPeptides products are sold exclusively for research and laboratory use.